Abstract Library

#1747 Clinical Characterization of Patients with Neuroendocrine Neoplasm of the Appendix in Ireland and in Italy: A Retrospective Study from Two Tertiary Institutions

Introduction: Appendiceal neuroendocrine neoplasms (aNEN) are rare tumors often diagnosed incidentally at appendectomy. Though most aNEN patients have a positive outcome, distant metastases may rarely occur and the identification of the patients at higher risk is required

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Cavalcoli F, Massironi S, Del Gobbo A, Fanetti I, Mulligan N,

Keywords: appendix, NEN, epidemiology,

#1565 Molecular Imaging of Late Somatostatin Receptor–Positive Metastases of Renal Cell Carcinoma in the Pancreas by Radiolabeled 111In SRS Octreotide Scan : A Rare Differential Diagnosis to Multiple Primary Pancreatic Neuroendocrine Tumors

Introduction: Somatostatin-Receptor Scintigraphy (SRS) has a sensitivity and specificity for pancreatic NETs (pNETs) of 90 and 80% respectively. SRS is indicated as first staging procedure and one of the most sensitive imaging modalities for well-differentiated neuroendocrine tumors, based on imaging of somatostatin receptors (SSRTs).

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Dimitriadis G

Authors: Dimitriadis G, Davies L, Randeva H, Weickert M,

Keywords: SRS, pNET, SSRTs, RCC,

#1421 Oxaliplatin-based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological Factors

Introduction: The role of chemotherapy in low/intermediate grade neuroendocrine tumors (NETs) is still debated.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Spada F

Authors: Spada F, Antonuzzo L, Marconcini R, Radice D, Antonuzzo A,

Keywords: Oxaliplatin, NETs,

#1150 Platelet Serotonin But Not Dopamine Concentrations Are Lower in Pancreatic Neuroendocrine Tumor and Renal Cell Carcinoma Patients Compared to Healthy Individuals.

Introduction: Platelets carry VEGF-A, serotonin and dopamine. Serotonin stimulates and dopamine inhibits tumor angiogenesis. We hypothesized that platelets are activated in tumor vasculature and release angiogenic factors, resulting in lower platelet serotonin and dopamine.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Peters M, Van Faassen M, Van Asselt S, Bouma G, Meijer C,

Keywords: Serotonin, dopamine, pancreatic neuroendocrine tumor, renal cell carcinoma.,

#994 Predictive Biomarkers of Response in Patients with Extrapulmonary Neuroendocrine Tumors (EPNET) Treated with Platin-based Chemotherapy

Introduction: EPNET, particularly advanced and Grade 3 (G3) tumors are often treated with chemotherapy. While many patients experience tumor response, those rarely live for more than two years. Predictive markers could potentially help us to tailor the best treatment for these patients (pts).

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Rego J

Authors: Rego J, Medeiros R, Braghiroli M, Bezerra Neto J, Munhoz R,

Keywords: biomarker, neuroendocrine tumors,